Robert Goeltz II Net Worth & Insider Trades
Robert Goeltz II - Chief Financial Officer, Arcus Biosciences, Inc
What is Robert Goeltz II's Net Worth?
The current estimated net worth of Arcus Biosciences, Inc's Chief Financial Officer, Robert Goeltz II, is estimated to be about $742.8K . Robert Goeltz II owns about 7,019 units of Arcus Biosciences, Inc common stock. In the last 2 years at Arcus Biosciences, Inc, Robert Goeltz II has sold an estimated value of $44.38K worth.
What is Robert Goeltz II's Past Insider Trading?
Robert Goeltz II's largest purchase order was 5,000 units , worth over $107.85K on September 9, 2020. Robert Goeltz II's largest sale order was 1,106 units , worth over $44.38K on December 20, 2021. In total, Robert Goeltz II has made about 5 transactions over 2 years of their time at Arcus Biosciences, Inc. Robert Goeltz II usually trades in March, January, December, August and September, with the busiest year in 2020 and 2021.
Robert Goeltz II
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Robert Goeltz II's' Mailing Address?
- Mailing address is 343 Oyster Point Blvd Suite 100 South San Francisco CA 94080 CA
Arcus Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Terry Rosen, Ph.D. | 2020 | $325,625 | - | $2,351,475 | $2,351,475 | - | $1,200 | $5,683,300 |
| Terry Rosen, Ph.D. | 2019 | $340,000 | - | $1,375,700 | $1,375,700 | - | $1,200 | $1,716,900 |
| Jennifer Jarrett | 2020 | $125,000 | - | $10,578,439 | $10,578,439 | $75,000 | $28,171 | $10,896,760 |
| William Grossman, M.D., Ph.D. | 2020 | $457,600 | - | $2,073,420 | $2,073,420 | $250,000 | $1,200 | $6,134,970 |
| William Grossman, M.D., Ph.D. | 2019 | $296,667 | $200,000 | $2,723,040 | $2,723,040 | $180,000 | $600 | $3,400,307 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1724521/000156459021019630/rcus-def14a_20210603.htm
What are Arcus Biosciences, Inc's Past Insider Trades?
Arcus Biosciences, Inc's most recent insider trade came on June 21, 2022 by Carolyn Tang Attorney-In-Fact who sold 2,922 units worth $62.67K . In the last 4 years, insiders at Arcus Biosciences, Inc have sold an estimated value of $6.32M and bought an estimated value of $227.36M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Terry Rosen, Chief Executive Officer, Jennifer Jarrett, Chief Operating Officer, and Juan Jaen, President .
Arcus Biosciences, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||